Browse 20 Life Science companies funded by Khosla Ventures. See funding amounts, founder contacts, and investment details.
EGenesis is a gene editing and genome engineering company developing human-compatible engineered organs to treat diseases.
Noetik is an AI-native biotechnology company that applies machine learning to large-scale human multimodal spatial omics datasets.
Anagenex is a seed stage biotechnology company building a novel platform for drug discovery focusing on difficult targets.
Menten AI develops peptide and protein therapeutics using machine learning and quantum computing.
Ultima Genomics is a developer of a low-cost sequencing platform.
The world’s leading solution for consolidating lab communication, inventory management, and lab supply purchasing.
Known Medicine combines patient-specific 3D cell culture and AI to translate drugs to clinical success
Tachyon Therapeutics develops novel, selective compounds to improve the treatment of cancer.
IgGenix is a biotechnology company.
Enzymit is a bioproduction platform company based on computational protein design and ‘cell-free' enzymatic manufacturing technology
Eva develops an accessible and non-invasive wearable device designed to detect breast cancer risks.
Rubedo Life Sciences focuses on developing medicines that target the specific cells responsible for aging, known as pathologic cells.
Kernel is a neuroscience company that specializes in developing brain-recording technologies.
SURGE Therapeutics seeks to dramatically improve cancer patient survival by disrupting cancer immunotherapy is deployed.
CHARM Therapeutics uses deep learning on 3D molecular configurations to develop molecule therapeutics to target pathogenic proteins.
Ukko is a biotechnology company focused on developing immunotherapies for the treatment of allergies and other immune-mediated diseases.
Moonwalk Biosciences operates a genomic medicine company that aims to provide a new class of precision epigenetic medications.
Excelsior Sciences applies AI and automated chemistry to simplify small-molecule discovery and accelerate overall drug development.
GEn1E is a clinical-stage multi-target AI platform. They develop novel, next-gen, immunomodulators for rare & inflammatory diseases.
BioAge Labs is a clinical-stage biotechnology company that develops therapeutics to treat obesity and metabolic diseases.
View all companies funded by Khosla Ventures across every industry and funding stage.
View Full Khosla Ventures Portfolio